Sanara MedTech Future Growth
Future criteria checks 1/6
Sanara MedTech's earnings are forecast to decline at 8.9% per annum while its annual revenue is expected to grow at 18.9% per year. EPS is expected to decline by 7.6% per annum.
Key information
-8.9%
Earnings growth rate
-7.6%
EPS growth rate
| Medical Equipment earnings growth | 17.5% |
| Revenue growth rate | 18.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Aug 2024 |
Recent future growth updates
Recent updates
Sanara MedTech Inc. (NASDAQ:SMTI) Looks Just Right With A 28% Price Jump
Sep 05
Here's Why Sanara MedTech (NASDAQ:SMTI) Can Afford Some Debt
Aug 14Sanara MedTech Inc.'s (NASDAQ:SMTI) Shares Not Telling The Full Story
May 23Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?
Nov 15Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)
May 22Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results
Mar 22Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure
Sep 06Sanara MedTech reports Q2 results
Aug 15Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation
Dec 31Sanara MedTech: Technology For Faster Healing Wounds
Dec 08Sanara Medtech inks exclusive partnership with Pixalere Healthcare
Jun 04Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth
May 18Neil Cataldi From Blueprint Discusses Sanara MedTech
May 03The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders
Feb 19
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?
Dec 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 96 | -10 | N/A | N/A | 1 |
| 12/31/2024 | 81 | -16 | N/A | N/A | 1 |
| 6/30/2024 | 72 | -7 | -3 | -3 | N/A |
| 3/31/2024 | 68 | -5 | -3 | -3 | N/A |
| 12/31/2023 | 65 | -4 | -4 | -3 | N/A |
| 9/30/2023 | 63 | -8 | -3 | -3 | N/A |
| 6/30/2023 | 60 | -9 | -4 | -6 | N/A |
| 3/31/2023 | 54 | -6 | -6 | -5 | N/A |
| 12/31/2022 | 46 | -8 | -6 | -6 | N/A |
| 9/30/2022 | 38 | -7 | -8 | -7 | N/A |
| 6/30/2022 | 30 | -8 | -9 | -6 | N/A |
| 3/31/2022 | 27 | -10 | -6 | -6 | N/A |
| 12/31/2021 | 24 | -8 | -6 | -5 | N/A |
| 9/30/2021 | 22 | -5 | -5 | -4 | N/A |
| 6/30/2021 | 20 | -4 | -3 | -3 | N/A |
| 3/31/2021 | 17 | -4 | -4 | -3 | N/A |
| 12/31/2020 | 16 | -4 | -6 | -4 | N/A |
| 9/30/2020 | 14 | -6 | -6 | -4 | N/A |
| 6/30/2020 | 13 | -5 | -6 | -4 | N/A |
| 3/31/2020 | 13 | -4 | -6 | -4 | N/A |
| 12/31/2019 | 12 | -3 | -4 | -2 | N/A |
| 9/30/2019 | 11 | -1 | -2 | -1 | N/A |
| 6/30/2019 | 10 | 0 | -1 | -1 | N/A |
| 3/31/2019 | 9 | 0 | 0 | 0 | N/A |
| 12/31/2018 | 9 | 0 | 0 | 1 | N/A |
| 9/30/2018 | 8 | 0 | 1 | 1 | N/A |
| 6/30/2018 | 7 | 0 | 0 | 0 | N/A |
| 3/31/2018 | 7 | 0 | N/A | 0 | N/A |
| 12/31/2017 | 6 | 0 | N/A | 0 | N/A |
| 9/30/2017 | 6 | 0 | N/A | 0 | N/A |
| 6/30/2017 | 6 | 0 | N/A | 1 | N/A |
| 3/31/2017 | 6 | -1 | N/A | 0 | N/A |
| 12/31/2016 | 6 | -1 | N/A | 0 | N/A |
| 9/30/2016 | 4 | -1 | N/A | 0 | N/A |
| 6/30/2016 | 4 | -2 | N/A | -1 | N/A |
| 3/31/2016 | 3 | -1 | N/A | -1 | N/A |
| 12/31/2015 | 3 | -2 | N/A | -1 | N/A |
| 9/30/2015 | 3 | -1 | N/A | -1 | N/A |
| 6/30/2015 | 3 | -2 | N/A | -1 | N/A |
| 3/31/2015 | 3 | -2 | N/A | -1 | N/A |
| 12/31/2014 | 3 | -3 | N/A | -2 | N/A |
| 9/30/2014 | 2 | -4 | N/A | -2 | N/A |
| 6/30/2014 | 2 | -5 | N/A | -2 | N/A |
| 3/31/2014 | 2 | -4 | N/A | -2 | N/A |
| 12/31/2013 | 2 | -4 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMTI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SMTI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SMTI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SMTI's revenue (18.9% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: SMTI's revenue (18.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SMTI's Return on Equity is forecast to be high in 3 years time